FI66861C - Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan - Google Patents
Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan Download PDFInfo
- Publication number
- FI66861C FI66861C FI790369A FI790369A FI66861C FI 66861 C FI66861 C FI 66861C FI 790369 A FI790369 A FI 790369A FI 790369 A FI790369 A FI 790369A FI 66861 C FI66861 C FI 66861C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- propylendiaminer
- disubstuffs
- antihypertensiv
- framstating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7803175 | 1978-02-06 | ||
FR7803175A FR2421888A1 (fr) | 1978-02-06 | 1978-02-06 | Amides d'alkylene-diamines et leur application en therapeutique |
FR7836819A FR2445323A2 (fr) | 1978-02-06 | 1978-12-29 | Amides d'alkylenediamines et leur application en therapeutique |
FR7836819 | 1978-12-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI790369A FI790369A (fi) | 1979-08-07 |
FI66861B FI66861B (fi) | 1984-08-31 |
FI66861C true FI66861C (fi) | 1984-12-10 |
Family
ID=26220430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI790369A FI66861C (fi) | 1978-02-06 | 1979-02-05 | Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan |
Country Status (23)
Country | Link |
---|---|
US (1) | US4315007A (no) |
JP (1) | JPS6023114B2 (no) |
AT (1) | AT365176B (no) |
AU (1) | AU521524B2 (no) |
BE (1) | BE873909A (no) |
CA (1) | CA1102330A (no) |
CH (1) | CH637122A5 (no) |
DE (1) | DE2904445C2 (no) |
DK (1) | DK159316C (no) |
ES (1) | ES477457A1 (no) |
FI (1) | FI66861C (no) |
FR (2) | FR2421888A1 (no) |
GB (1) | GB2013679B (no) |
GR (1) | GR66846B (no) |
IE (1) | IE47812B1 (no) |
IL (1) | IL56578A (no) |
IT (1) | IT1192347B (no) |
LU (1) | LU80880A1 (no) |
NL (2) | NL181482C (no) |
NO (1) | NO151463C (no) |
NZ (1) | NZ189553A (no) |
PT (1) | PT69178A (no) |
SE (1) | SE449360B (no) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2466462A2 (fr) * | 1978-02-06 | 1981-04-10 | Synthelabo | Derives d'alkylenediamines, leur preparation et leur application en therapeutique |
EP0105838B1 (en) * | 1982-09-30 | 1989-06-21 | William John Louis | 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them |
JPS6093016A (ja) * | 1983-10-25 | 1985-05-24 | Natl House Ind Co Ltd | クランプ搬送装置 |
FR2577803B1 (fr) * | 1985-02-26 | 1987-04-03 | Synthelabo | Compositions pharmaceutiques a base de nifedipine et d'alfuzosine |
FR2570275B1 (fr) * | 1984-09-14 | 1986-11-21 | Synthelabo | Compositions pharmaceutiques a base de diltiazem et d'alfusozine |
FR2577804B1 (fr) * | 1985-02-26 | 1987-03-27 | Synthelabo | Compositions pharmaceutiques a base de verapamil et d'alfuzosine |
EP0189336A1 (fr) * | 1985-01-18 | 1986-07-30 | Synthelabo | Compositions pharmaceutiques contenant un alpha-bloquant et un antagoniste du calcium |
FR2582513B1 (fr) * | 1985-05-28 | 1988-08-05 | Synthelabo | Compositions pharmaceutiques contenant de l'alfuzosine |
LU86672A1 (fr) * | 1986-11-19 | 1988-06-13 | Oreal | Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives d'alkylene diamino quinazoline |
YU70890A (en) * | 1989-04-21 | 1992-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for obtaining quinazoline derivatives |
NZ241979A (en) * | 1991-03-20 | 1996-01-26 | Merck & Co Inc | Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker |
FR2694495B1 (fr) * | 1992-08-05 | 1994-09-23 | Synthelabo | Préparation pharmaceutique transdermique contenant de l'alfuzosine. |
JPH07206857A (ja) * | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
FR2717388B1 (fr) * | 1994-03-21 | 1996-11-22 | Synthelabo | Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine. |
US6313294B1 (en) | 1998-02-04 | 2001-11-06 | Development Center For Biotechnology | Process for preparing amides |
NZ510685A (en) | 1998-09-30 | 2003-10-31 | Takeda Chemical Industries Ltd | Drugs for improving vesical excretory strength |
WO2001068615A1 (en) * | 2000-03-13 | 2001-09-20 | Chemrx Advanced Technologies, Inc. | Quinazoline synthesis |
US20020065286A1 (en) * | 2000-08-21 | 2002-05-30 | Davies Michael John | Treatment of wounds |
US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
US20030229001A1 (en) * | 2002-01-31 | 2003-12-11 | Pfizer Inc. | Treatment of male sexual dysfunction |
GB0219961D0 (en) | 2002-08-28 | 2002-10-02 | Pfizer Ltd | Oxytocin inhibitors |
US7323462B2 (en) * | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
WO2004054560A1 (en) | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Alpha-2-delta ligand to treat lower urinary tract symptoms |
PA8597401A1 (es) * | 2003-03-14 | 2005-05-24 | Pfizer | Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
US20050065158A1 (en) * | 2003-07-16 | 2005-03-24 | Pfizer Inc. | Treatment of sexual dysfunction |
US7291640B2 (en) * | 2003-09-22 | 2007-11-06 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
US20050267096A1 (en) * | 2004-05-26 | 2005-12-01 | Pfizer Inc | New indazole and indolone derivatives and their use pharmaceuticals |
US20050288270A1 (en) * | 2004-05-27 | 2005-12-29 | Pfizer Inc | New aminopyridine derivatives and their use as pharmaceuticals |
EP1789412B1 (en) * | 2004-09-16 | 2008-05-07 | Hetero Drugs Limited | Crystalline alfuzosin base |
EP1863484A1 (en) * | 2005-03-21 | 2007-12-12 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
WO2006100557A1 (en) * | 2005-03-21 | 2006-09-28 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
CA2618103A1 (en) * | 2005-08-10 | 2007-02-15 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
US20070066824A1 (en) * | 2005-09-22 | 2007-03-22 | Anumula Raghupathi R | Preparation of alfuzosin |
US20070105880A1 (en) * | 2005-11-08 | 2007-05-10 | Torrent Pharmaceuticals Limited | Process for the preparation of alfuzosin |
WO2007074364A1 (en) * | 2005-12-26 | 2007-07-05 | Aurobindo Pharma Limited | Process for the preparation of alfuzosin |
CN100564376C (zh) * | 2006-09-19 | 2009-12-02 | 浙江华纳药业有限公司 | 阿夫唑嗪的制备方法 |
CN101190890B (zh) * | 2006-11-30 | 2011-04-27 | 江苏豪森药业股份有限公司 | 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺 |
US20080160081A1 (en) * | 2006-12-11 | 2008-07-03 | Mutual Pharmaceutical Company, Inc. | Alfuzosin formulations, methods of making, and methods of use |
US20100092556A1 (en) * | 2006-12-11 | 2010-04-15 | Kristin Arnold | Alfuzosin formulations, methods of making, and methods of use |
EP2152697A2 (en) | 2007-05-04 | 2010-02-17 | Actavis Group PTC EHF | Process for the preparation of alfuzosin and salts thereof |
WO2009001369A1 (en) * | 2007-06-22 | 2008-12-31 | Alembic Limited | An improved process for the preparation of alfuzosin hydrochloride |
WO2009007987A1 (en) * | 2007-07-11 | 2009-01-15 | Alembic Limited | An improved process for the preparation of alfuzosin and its novel polymorph |
NZ582950A (en) * | 2007-08-02 | 2011-06-30 | Cipla Ltd | Process for the preparation of alfuzosin hydrochloride |
US20090076043A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched alfuzosin |
WO2010083360A2 (en) * | 2009-01-16 | 2010-07-22 | Mutual Pharmaceutical Company, Inc. | Controlled-release formulations |
CN107998090A (zh) * | 2017-12-30 | 2018-05-08 | 威海贯标信息科技有限公司 | 一种阿夫唑嗪片组合物 |
CN113801069B (zh) * | 2020-06-15 | 2024-03-15 | 鲁南制药集团股份有限公司 | 一种盐酸阿夫唑嗪中间体化合物 |
CN114573569B (zh) * | 2022-03-30 | 2023-07-04 | 邦恩泰(山东)生物医药科技集团股份有限公司 | 一种异喹啉类化合物的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663706A (en) * | 1969-09-29 | 1972-05-16 | Pfizer | Use of 2,4-diaminoquinazolines as hypotensive agents |
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
US4060615A (en) * | 1976-02-18 | 1977-11-29 | Mead Johnson & Company | 2-Piperazinyl-6,7-dimethoxyquinazolines |
DK140695C (da) * | 1976-05-07 | 1980-05-12 | Synthelabo | Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf |
FR2362630A1 (fr) * | 1976-08-24 | 1978-03-24 | Synthelabo | Derives d'alkylenediamines |
FR2350101A1 (fr) * | 1976-05-07 | 1977-12-02 | Synthelabo | Nouvelles guanidines cyclisees |
FR2389613A2 (en) * | 1977-05-05 | 1978-12-01 | Synthelabo | Antihypertensive 4-amino-6,7-di:methoxy-quinazolyl alkylene di:amine - prepd. from a 2-halo-quinazoline and an alkylene di:amine |
-
1978
- 1978-02-06 FR FR7803175A patent/FR2421888A1/fr active Granted
- 1978-12-29 FR FR7836819A patent/FR2445323A2/fr active Granted
-
1979
- 1979-02-02 GR GR50581A patent/GR66846B/el unknown
- 1979-02-02 BE BE0/193248A patent/BE873909A/xx not_active IP Right Cessation
- 1979-02-02 AU AU43895/79A patent/AU521524B2/en not_active Expired
- 1979-02-02 NZ NZ189553A patent/NZ189553A/xx unknown
- 1979-02-02 DK DK046079A patent/DK159316C/da not_active IP Right Cessation
- 1979-02-02 IL IL56578A patent/IL56578A/xx unknown
- 1979-02-05 FI FI790369A patent/FI66861C/fi not_active IP Right Cessation
- 1979-02-05 NO NO790358A patent/NO151463C/no unknown
- 1979-02-05 ES ES477457A patent/ES477457A1/es not_active Expired
- 1979-02-05 LU LU80880A patent/LU80880A1/fr unknown
- 1979-02-05 IE IE210/79A patent/IE47812B1/en not_active IP Right Cessation
- 1979-02-05 AT AT0084279A patent/AT365176B/de not_active IP Right Cessation
- 1979-02-05 SE SE7900987A patent/SE449360B/sv not_active IP Right Cessation
- 1979-02-05 CA CA320,864A patent/CA1102330A/en not_active Expired
- 1979-02-05 IT IT19908/79A patent/IT1192347B/it active Protection Beyond IP Right Term
- 1979-02-05 CH CH112079A patent/CH637122A5/fr not_active IP Right Cessation
- 1979-02-05 PT PT7969178A patent/PT69178A/pt active IP Right Revival
- 1979-02-05 JP JP54012737A patent/JPS6023114B2/ja not_active Expired
- 1979-02-06 GB GB79403279A patent/GB2013679B/en not_active Expired
- 1979-02-06 NL NLAANVRAGE7900917,A patent/NL181482C/xx not_active IP Right Cessation
- 1979-02-06 DE DE2904445A patent/DE2904445C2/de not_active Expired
- 1979-12-10 US US06/099,622 patent/US4315007A/en not_active Expired - Lifetime
-
1993
- 1993-05-28 NL NL930043C patent/NL930043I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI66861C (fi) | Foerfarande foer framstaellning av n,n2-disubstituerade propylendiaminer med antihypertensiv verkan | |
FI59990C (fi) | Foerfarande foer framstaellning av pao centralnervsystemet verkande racemiska eller optiskt aktiva arylpiperaziner samt deras syraadditionssalter | |
US20050171357A1 (en) | Process for preparing indolinone derivatives | |
JPS626703B2 (no) | ||
FR2644786A1 (fr) | Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
HU189886B (en) | Process for preparing /2-oxo-1,2,3,5-tetrahydro-imidazo/2,1-b/quinazolinyl/-oxy-alkane-carboxylic acid amides and pharmaceutical compositions containing such compounds | |
JPH09500883A (ja) | α1A−アドレナリン受容体アンタゴニストとしてのピペラジン誘導体 | |
JPS6136260A (ja) | 新規なイソインドリニル‐アルキル‐ピペラジン類およびその製法 | |
US4341893A (en) | Quinazoline derivatives | |
FI77456B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-/2-/4-(2-metoxifenyl) -1-piperazinyl/etyl/-2,4-(1h,3h)-kinazolindionderivat. | |
US3200151A (en) | Arylaminoalkyl guanidines | |
HU182070B (en) | Process for producing phenyl-piperazine derivatives | |
CA1130806A (en) | 1,2,4-oxadiazole derivatives, their preparation and pharmaceutical use | |
HUT70183A (en) | Amidines derivated from 3-(amino-ethyl)-indoles, process for producing thereof and pharmaceutical compositions comprising them | |
FR2643373A1 (fr) | Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
IE43222B1 (en) | Piperazine derivatives | |
Balasubramanian et al. | Synthesis of some spiroheterocycles | |
IE45423B1 (en) | Process for hypotensive 2-(4-substituted piperazin-1-yl)-4-aminoquinazolines | |
FR2466462A2 (fr) | Derives d'alkylenediamines, leur preparation et leur application en therapeutique | |
JPS6022714B2 (ja) | キナゾリン誘導体及びその製造法 | |
FI56530C (fi) | Foerfarande foer framstaellning av 6-sulfamyl-1,2,3,4-tetrahydro-4-kinazolinoner | |
US5322846A (en) | 4-methylthiazole derivatives, their methods of preparation and the pharmaceutical compositions in which they are present | |
CA2035988A1 (en) | Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediaes | |
Kedar et al. | Synthesis of 5-imidazolones from 2-methyl-4-(4-substituted benzylidene)-5-oxazolones | |
FI57403B (fi) | Foerfarande foer framstaellning av blodtryckssaenkande 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired | ||
MA | Patent expired |
Owner name: SYNTHELABO |